Gloyer, L., Golumba-Nagy, V, Meyer, A., Yan, S., Schiller, J., Breuninger, M., Jochimsen, D. and Kofler, D. M. (2022). Adenosine receptor A2a blockade by caffeine increases IFN-gamma production in Th1 cells from patients with rheumatoid arthritis. Scand. J. Rheumatol., 51 (4). S. 279 - 284. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1502-7732
Full text not available from this repository.Abstract
Objective Studies indicate that caffeine uptake may be a risk factor for rheumatoid arthritis (RA), but a definitive link between caffeine consumption and RA has not been established. This study aimed to investigate the interplay between caffeine, adenosine receptor A2a, and interferon-gamma (IFN-gamma) production in CD4(+) T cells from RA patients. Method Peripheral blood mononuclear cells were obtained from the peripheral blood of healthy individuals and patients with RA. CD4(+) T cells were isolated using the magnetic activated cell sorting technique and cultured in vitro with caffeine or mock control. In addition, adenosine was used as a competitive inhibitor of caffeine. After 48 h, expression of IFN-gamma and interleukin-17 (IL-17) was analysed by flow cytometry. Ex vivo expression levels of adenosine receptor A2a were also assessed. Results Caffeine promoted IFN-gamma production in Th1 cells in vitro. Significantly higher concentrations of caffeine were required to increase IFN-gamma levels in Th1 cells from healthy individuals compared to Th1 cells from patients with RA. Moreover, ex vivo levels of adenosine receptor A2a expression on CD4(+) T cells were significantly higher in RA than in healthy individuals. Caffeine-driven IFN-gamma production was completely reversed by adenosine, a competitive agonist of adenosine receptor A2a. In contrast to IFN-gamma, production of IL-17 was not affected by caffeine. Conclusion Caffeine promotes IFN-gamma production in Th1 cells from RA patients in vitro by competitive inhibition of adenosine receptor A2a. Excessive coffee consumption could contribute to T-cell activation and inflammation in RA.
Item Type: | Journal Article | ||||||||||||||||||||||||||||||||||||
Creators: |
|
||||||||||||||||||||||||||||||||||||
URN: | urn:nbn:de:hbz:38-663643 | ||||||||||||||||||||||||||||||||||||
DOI: | 10.1080/03009742.2021.1995956 | ||||||||||||||||||||||||||||||||||||
Journal or Publication Title: | Scand. J. Rheumatol. | ||||||||||||||||||||||||||||||||||||
Volume: | 51 | ||||||||||||||||||||||||||||||||||||
Number: | 4 | ||||||||||||||||||||||||||||||||||||
Page Range: | S. 279 - 284 | ||||||||||||||||||||||||||||||||||||
Date: | 2022 | ||||||||||||||||||||||||||||||||||||
Publisher: | TAYLOR & FRANCIS LTD | ||||||||||||||||||||||||||||||||||||
Place of Publication: | ABINGDON | ||||||||||||||||||||||||||||||||||||
ISSN: | 1502-7732 | ||||||||||||||||||||||||||||||||||||
Language: | English | ||||||||||||||||||||||||||||||||||||
Faculty: | Unspecified | ||||||||||||||||||||||||||||||||||||
Divisions: | Unspecified | ||||||||||||||||||||||||||||||||||||
Subjects: | no entry | ||||||||||||||||||||||||||||||||||||
Uncontrolled Keywords: |
|
||||||||||||||||||||||||||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/66364 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |